ロード中...
Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5‐HT2c receptor—NPY pathway
AIMS: Many patients taking risperidone for the treatment of psychiatric disorders experience substantial body weight gain. Researchers have speculated that risperidone induces obesity by modulating central signals; however, the precise central mechanisms involved remain to be fully elucidated. METHO...
保存先:
| 出版年: | CNS Neurosci Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163792/ https://ncbi.nlm.nih.gov/pubmed/31880085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13281 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|